Kissei Pharmaceutical Co., Ltd. (4547)

Name: Kissei Pharmaceutical Co., Ltd. (4547) — histórico de demonstrações financeiras
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Histórico de receita, lucros e fluxo de caixa das demonstrações financeiras oficiais.

Healthcare · Wall Street (EUA) · Última atualização: 2026-10-02

Kissei Pharmaceutical Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in Japan and internationally. It offers Calogra tablets, for the treatment of ulcerative colitis; Tabneos capsules for the treatment of microscopic polyangiitis and granulomatous polyangiitis; Corsuba Intravenous Dialysis Syringe for the treatment of chronic idiopathic thrombocytopenic purpura; Beova tablets for the treatment of overactive bladder treatment; and Darbepoetin Alfa BS injection JCR for the treatment of renal anemia.

Números-chave

Capitalização de mercado: JPY 155 billion
Receita (exercício encerrado em 2026-03-31): JPY 97.4B
Lucro líquido: JPY 13.8B
Margem bruta: 47.0%
Margem líquida: 14.1%

Ver gráficos interativos e demonstrações completas → Modelo de avaliação (DCF) →

Demonstração de resultados anual

Demonstração de resultados	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Receita total	JPY 97.4B	JPY 88.3B	JPY 75.6B	JPY 67.5B
Lucro bruto	JPY 45.8B	JPY 44.1B	JPY 37.3B	JPY 32.4B
Resultado Operacional (EBIT)	(JPY 2.9B)	JPY 5.8B	JPY 4.0B	(JPY 1.1B)
Resultado líquido	JPY 13.8B	JPY 12.0B	JPY 11.2B	JPY 10.5B

Fonte: relatórios públicos da empresa (SEC). Verifique no SEC EDGAR antes de confiar em qualquer número.

Balanços, fluxos de caixa, dados trimestrais e indicadores completos no visualizador interativo de 4547. /companies/us/4547

Empresas semelhantes

4521 · Kaken Pharmaceutical Co., Ltd.

As informações deste site são apenas educacionais e informativas; não constituem recomendação de investimento. Não publicamos preços-alvo nem recomendações.

English version →Todas as ações

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.